149 related articles for article (PubMed ID: 35920528)
1. Treatment outcomes and prognostic factors of childhood acute lymphoblastic leukemia in a low-middle income population: A multi-institutional report from Pakistan.
Nisar I; Shahid S; Yousuf F; Lakhani LS; Ashraf S; Imam U; Zaheer J; Belgaumi A; Fadoo Z
Pediatr Blood Cancer; 2023 Feb; 70(2):e29889. PubMed ID: 35920528
[No Abstract] [Full Text] [Related]
2. Clinical features and induction outcome of childhood acute lymphoblastic leukemia in a lower/middle income population: A multi-institutional report from Pakistan.
Fadoo Z; Nisar I; Yousuf F; Lakhani LS; Ashraf S; Imam U; Zaheer J; Naqvi A; Belgaumi A
Pediatr Blood Cancer; 2015 Oct; 62(10):1700-8. PubMed ID: 25982135
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of BCR-ABL fusion transcripts with poor prognostic impact among adult ALL patients: report from Pakistan.
Faiz M; Iqbal QJ; Qureshi A
Asia Pac J Clin Oncol; 2011 Mar; 7(1):47-55. PubMed ID: 21332651
[TBL] [Abstract][Full Text] [Related]
4. Retrospective review of pediatric patients with acute lymphoblastic leukemia: a single center experience.
Khalid S; Moiz B; Adil SN; Khurshid M
Indian J Pathol Microbiol; 2010; 53(4):704-10. PubMed ID: 21045397
[TBL] [Abstract][Full Text] [Related]
5. Adult acute lymphoblastic leukemia.
Adil SN; Usman M
J Pak Med Assoc; 2004 Sep; 54(9):444. PubMed ID: 15518363
[No Abstract] [Full Text] [Related]
6. Treatment of childhood acute lymphoblastic leukemia in central America: a lower-middle income countries experience.
Navarrete M; Rossi E; Brivio E; Carrillo JM; Bonilla M; Vasquez R; Peña A; Fu L; Martinez R; Espinoza CM; Lacayo LF; Rodriguez H; Batista R; Barr R; Howard SC; Ribeiro RC; Masera G; Biondi A; Conter V; Valsecchi MG
Pediatr Blood Cancer; 2014 May; 61(5):803-9. PubMed ID: 24376115
[TBL] [Abstract][Full Text] [Related]
7. Survival outcome of childhood acute lymphoblastic leukemia in India: a resource-limited perspective of more than 40 years.
Kulkarni KP; Arora RS; Marwaha RK
J Pediatr Hematol Oncol; 2011 Aug; 33(6):475-9. PubMed ID: 21792045
[TBL] [Abstract][Full Text] [Related]
8. Treatment of Childhood Acute Lymphoblastic Leukemia: Prognostic Factors and Clinical Advances.
Vrooman LM; Silverman LB
Curr Hematol Malig Rep; 2016 Oct; 11(5):385-94. PubMed ID: 27502091
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in childhood acute lymphoblastic leukemia.
Mastrangelo R
Pediatr Hematol Oncol; 1995; 12(5):421-4. PubMed ID: 8519624
[No Abstract] [Full Text] [Related]
10. Strategies to improve outcomes of children with cancer in low-income countries.
Howard SC; Ribeiro RC; Pui CH
Eur J Cancer; 2005 Jul; 41(11):1584-7. PubMed ID: 15979305
[No Abstract] [Full Text] [Related]
11. Newly diagnosed childhood acute lymphoblastic leukemia: update on prognostic factors and treatment.
Silverman LB; Sallan SE
Curr Opin Hematol; 2003 Jul; 10(4):290-6. PubMed ID: 12799535
[TBL] [Abstract][Full Text] [Related]
12. [Recommendations for diagnosis and treatment of acute lymphoblastic leukemia in childhood (3rd revised version)].
;
Zhonghua Er Ke Za Zhi; 2006 May; 44(5):392-5. PubMed ID: 16780726
[No Abstract] [Full Text] [Related]
13. Childhood acute lymphoblastic leukaemia: experience from a single tertiary care facility of Pakistan.
Mushtaq N; Fadoo Z; Naqvi A
J Pak Med Assoc; 2013 Nov; 63(11):1399-404. PubMed ID: 24392527
[TBL] [Abstract][Full Text] [Related]
14. Superior vena cava obstruction in childhood acute lymphoblastic leukemia.
Marwaha RK; Kulkarni KP
Indian Pediatr; 2011 Jan; 48(1):78-9. PubMed ID: 21317479
[No Abstract] [Full Text] [Related]
15. Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.
Burmeister T; Gökbuget N; Schwartz S; Fischer L; Hubert D; Sindram A; Hoelzer D; Thiel E
Haematologica; 2010 Feb; 95(2):241-6. PubMed ID: 19713226
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of children with acute lymphoblastic leukemia in a middle-income developing country: high mortalities, early relapses, and poor survival.
Abdelmabood S; Fouda AE; Boujettif F; Mansour A
J Pediatr (Rio J); 2020; 96(1):108-116. PubMed ID: 30240631
[TBL] [Abstract][Full Text] [Related]
17. Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries.
Caniza MA; Odio C; Mukkada S; Gonzalez M; Ceppi F; Chaisavaneeyakorn S; Apiwattanakul N; Howard SC; Conter V; Bonilla M
Expert Rev Hematol; 2015 Oct; 8(5):627-45. PubMed ID: 26211675
[TBL] [Abstract][Full Text] [Related]
18. Myeloid-associated antigen expression in childhood acute lymphoblastic leukemia. Austrian Pediatric Oncology Group.
Fink FM; Köller U; Mayer H; Haas OA; Grümayer ER; Urban C; Dengg K; Mutz I; Tüchler H; Gatterer-Menz I
Recent Results Cancer Res; 1993; 131():67-75. PubMed ID: 8210660
[No Abstract] [Full Text] [Related]
19. Differing Outcomes of Patients with High Hyperdiploidy and ETV6-RUNX1 Rearrangement in Korean Pediatric Precursor B Cell Acute Lymphoblastic Leukemia.
Lee JW; Kim S; Jang PS; Chung NG; Cho B
Cancer Res Treat; 2021 Apr; 53(2):567-575. PubMed ID: 33070555
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of plasma levels of thrombomodulin and von Willebrand factor in Egyptian children with acute lymphoblastic leukemia.
Hagag AA; Abdel-Lateef AE; Aly R
J Oncol Pharm Pract; 2014 Oct; 20(5):356-61. PubMed ID: 24243921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
